GlassScriptPhysician profile
Candice Choi
NPI 1710496260
$1,625.95
in general payments reported to CMS, 2019-2025
13 companies · $501 in 2025
The $501 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $67.02 · 2022: $337 · 2023: $133 · 2024: $588 · 2025: $501.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,222.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,221.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Baxter Healthcare | $844.26 | 2024-2025 | Floseal, Perclot, Preveleak |
| Abiomed | $438.58 | 2022-2025 | Impella |
| Atricure, INC. | $99.96 | 2021-2022 | |
| Incyte Corporation | $42.28 | 2022 | |
| Medtronic, INC. | $40.60 | 2023 | Avalus |
| Haemonetics Corporation | $29.22 | 2024 | Teg6s Hemostasis System |
| Nabriva Therapeutics, Plc | $28.37 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $25.36 | 2022 | |
| Amgen INC. | $24.29 | 2022 | |
| Sun Pharmaceutical Industries INC. | $13.94 | 2022 | |
| Lilly USA, LLC | $13.89 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $13.04 | 2023 | Jardiance |
| Janssen Biotech, INC. | $12.16 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Candice Choi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.